CL2012000694A1 - Composicion farmaceutica que comprende 200-800mg de ceftarolina fosamilo, l-arginina y menos de 2% de un aducto de l-arginina; uso para tratar infecciones de la piel y neumonia bacteriana. - Google Patents
Composicion farmaceutica que comprende 200-800mg de ceftarolina fosamilo, l-arginina y menos de 2% de un aducto de l-arginina; uso para tratar infecciones de la piel y neumonia bacteriana.Info
- Publication number
- CL2012000694A1 CL2012000694A1 CL2012000694A CL2012000694A CL2012000694A1 CL 2012000694 A1 CL2012000694 A1 CL 2012000694A1 CL 2012000694 A CL2012000694 A CL 2012000694A CL 2012000694 A CL2012000694 A CL 2012000694A CL 2012000694 A1 CL2012000694 A1 CL 2012000694A1
- Authority
- CL
- Chile
- Prior art keywords
- arginine
- ceftaroline
- pharmaceutical composition
- phosamyl
- adduct
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Método para tratar una infección bacteriana con ceftarolina en solución acuosa; composición farmacéutica que comprende ceftarolina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24412009P | 2009-09-21 | 2009-09-21 | |
US29490110P | 2010-01-14 | 2010-01-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2012000694A1 true CL2012000694A1 (es) | 2012-08-31 |
Family
ID=43757152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2012000694A CL2012000694A1 (es) | 2009-09-21 | 2012-03-20 | Composicion farmaceutica que comprende 200-800mg de ceftarolina fosamilo, l-arginina y menos de 2% de un aducto de l-arginina; uso para tratar infecciones de la piel y neumonia bacteriana. |
Country Status (23)
Country | Link |
---|---|
US (2) | US20110071114A1 (es) |
EP (1) | EP2480236A4 (es) |
KR (1) | KR20120083344A (es) |
CN (1) | CN102781451A (es) |
AU (1) | AU2010295269B2 (es) |
BR (1) | BR112012006250B1 (es) |
CA (1) | CA2774772A1 (es) |
CL (1) | CL2012000694A1 (es) |
CO (1) | CO6531417A2 (es) |
CR (1) | CR20120137A (es) |
CU (1) | CU20120048A7 (es) |
DO (1) | DOP2012000077A (es) |
EA (1) | EA029149B1 (es) |
EC (1) | ECSP12011739A (es) |
GT (1) | GT201200082A (es) |
HN (1) | HN2012000585A (es) |
IL (1) | IL218349A0 (es) |
MX (2) | MX2012003411A (es) |
NI (1) | NI201200045A (es) |
PE (2) | PE20121819A1 (es) |
SG (1) | SG178936A1 (es) |
WO (1) | WO2011035305A1 (es) |
ZA (1) | ZA201202924B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2951171A1 (fr) * | 2009-10-09 | 2011-04-15 | Novexel | Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation |
TWI565706B (zh) | 2011-06-17 | 2017-01-11 | 阿斯特捷利康公司 | 用於製備包括反-7-酮基-6-(磺酸氧基)-1,6-二氮雜雙環[3,2,1]辛烷-2-甲醯胺之雜環化合物及其鹽類之方法 |
CN107621512B (zh) * | 2017-11-02 | 2020-07-31 | 扬子江药业集团有限公司 | 一种柱前衍生化法测定头孢洛林酯侧链酰氯纯度的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW473479B (en) * | 1997-12-19 | 2002-01-21 | Takeda Chemical Industries Ltd | Phosphonocephem derivatives, their production and use |
EP1310502B1 (en) * | 2000-08-10 | 2009-05-20 | Takeda Pharmaceutical Company Limited | Phosphonocephem compound |
US20030186339A1 (en) * | 2001-05-17 | 2003-10-02 | Mcgill University | Individualization of therapy with antibiotic agents |
EP2266590A3 (en) * | 2002-02-22 | 2011-04-20 | Shire LLC | Active agent delivery sytems and methods for protecting and administering active agents |
AU2008302201A1 (en) * | 2007-09-21 | 2009-03-26 | Astrazeneca Ab | Soluble dosage forms containing cephem derivatives suitable for parenteral administration |
-
2010
- 2010-09-21 BR BR112012006250-6A patent/BR112012006250B1/pt active IP Right Grant
- 2010-09-21 KR KR1020127007154A patent/KR20120083344A/ko not_active Application Discontinuation
- 2010-09-21 CA CA2774772A patent/CA2774772A1/en not_active Abandoned
- 2010-09-21 CN CN2010800537030A patent/CN102781451A/zh active Pending
- 2010-09-21 PE PE2012000354A patent/PE20121819A1/es not_active Application Discontinuation
- 2010-09-21 AU AU2010295269A patent/AU2010295269B2/en active Active
- 2010-09-21 PE PE2016002751A patent/PE20171176A1/es unknown
- 2010-09-21 US US12/887,140 patent/US20110071114A1/en not_active Abandoned
- 2010-09-21 WO PCT/US2010/049659 patent/WO2011035305A1/en active Application Filing
- 2010-09-21 EA EA201200501A patent/EA029149B1/ru unknown
- 2010-09-21 SG SG2012014510A patent/SG178936A1/en unknown
- 2010-09-21 EP EP10818022.5A patent/EP2480236A4/en not_active Withdrawn
- 2010-09-21 MX MX2012003411A patent/MX2012003411A/es unknown
- 2010-09-21 MX MX2012003201A patent/MX2012003201A/es not_active Application Discontinuation
-
2012
- 2012-02-27 IL IL218349A patent/IL218349A0/en unknown
- 2012-03-20 CL CL2012000694A patent/CL2012000694A1/es unknown
- 2012-03-20 HN HN2012000585A patent/HN2012000585A/es unknown
- 2012-03-21 CR CR20120137A patent/CR20120137A/es unknown
- 2012-03-21 EC ECSP12011739 patent/ECSP12011739A/es unknown
- 2012-03-21 CO CO12048072A patent/CO6531417A2/es not_active Application Discontinuation
- 2012-03-21 CU CU2012000048A patent/CU20120048A7/es unknown
- 2012-03-21 GT GT201200082A patent/GT201200082A/es unknown
- 2012-03-21 DO DO2012000077A patent/DOP2012000077A/es unknown
- 2012-03-21 NI NI201200045A patent/NI201200045A/es unknown
- 2012-04-20 ZA ZA2012/02924A patent/ZA201202924B/en unknown
-
2015
- 2015-05-27 US US14/722,495 patent/US9629861B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
SG178936A1 (en) | 2012-04-27 |
DOP2012000077A (es) | 2012-05-31 |
NI201200045A (es) | 2012-11-02 |
HN2012000585A (es) | 2015-06-15 |
MX2012003411A (es) | 2012-04-30 |
ECSP12011739A (es) | 2012-05-30 |
US20110071114A1 (en) | 2011-03-24 |
GT201200082A (es) | 2014-12-22 |
EA201200501A1 (ru) | 2012-10-30 |
CN102781451A (zh) | 2012-11-14 |
BR112012006250B1 (pt) | 2021-07-06 |
CU20120048A7 (es) | 2012-10-15 |
BR112012006250A2 (pt) | 2016-05-31 |
PE20171176A1 (es) | 2017-08-22 |
US20150258126A1 (en) | 2015-09-17 |
CA2774772A1 (en) | 2011-03-24 |
EP2480236A4 (en) | 2013-04-17 |
ZA201202924B (en) | 2012-12-27 |
EP2480236A1 (en) | 2012-08-01 |
CR20120137A (es) | 2012-05-28 |
WO2011035305A1 (en) | 2011-03-24 |
AU2010295269A1 (en) | 2012-04-12 |
AU2010295269B2 (en) | 2014-06-05 |
KR20120083344A (ko) | 2012-07-25 |
EA029149B1 (ru) | 2018-02-28 |
IL218349A0 (en) | 2012-04-30 |
PE20121819A1 (es) | 2013-02-01 |
US9629861B2 (en) | 2017-04-25 |
MX2012003201A (es) | 2012-05-08 |
CO6531417A2 (es) | 2012-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201791850A1 (ru) | Борсодержащие малые молекулы | |
UA107423C2 (en) | Fluoro-pyridinone derivatives useful as antibacterial agents | |
EA201270566A1 (ru) | Противомикробные соединения и способы их получения и применения | |
AR082381A1 (es) | Composicion acuosa que contiene bromhexina | |
EA201270567A1 (ru) | Противомикробные соединения и способы их получения и применения | |
CL2012001336A1 (es) | Composicion farmaceutica solida de daptomicina preparada por liofilizacion de una solucion acuosa que comprende daptomicina y al menos un excipiente seleccionado de glicina y un azucar no reductor con un ph de 6,5-7,5; producto farmaceutico; metodo de fabricacion; uso para tratar infecciones bacterianas. | |
CL2008001367A1 (es) | Compuestos derivados de heterociclos nitrogenados sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una infeccion bacteriana. | |
CL2014000470A1 (es) | Compuestos derivados del acido 2-oxo-piridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para tratar o mejorar una infeccion bacteriana. | |
BRPI0913300A2 (pt) | composto, processo para o preparo e uso do mesmo, método de tratamento de infecção bacteriana em um animal, e, composição farmacêutica. | |
CL2009000902A1 (es) | Composicion que comprende posaconazol disuelto o disperso molecularmente en un polimero derivado de hidroxipropilcelulosa; formulacion farmaceutica que comprende a la composion; un proceso para preparar a la composicion mediante fusioextrusion; y su uso para tratar una infeccion micotica. | |
CL2011002639A1 (es) | Cepa bacteriana de mycoplasma bovis atenuada avirulenta; composicion inmunogenica que la comprende; y uso para fabricar un medicamento para infecciones producidas por m. bovis. | |
CL2012003266A1 (es) | Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas; composicion farmacéutica y/o dermocosmética antimicrobiana que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo ; metodo para tratar y/o prevenir a un paciente que tiene una infeccion microbiana. | |
BR112014008700A2 (pt) | composições úteis no tratamento de nefropatia e processos para preparação das mesmas | |
MX2016003791A (es) | Composiciones y método para desestabilizar, alterar y dispersar biopelículas. | |
FI20120287A (fi) | Hartsihappoja sisältävä vesikoostumus käytettäväksi antimikrobisena hoitoaineena ja lisäaineena | |
CL2011003327A1 (es) | Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales. | |
CL2007002862A1 (es) | Uso del factor de crecimiento epidermico (egf) para tratar neuropatia sensitivo-motora, dolorosa y manifestaciones de neuritis isquemicas; composicion farmaceutica que comprende egf; y uso de la composicion antes dicha. | |
CL2012002902A1 (es) | Cepas de bacteriofagos especifica contra bacterias pertenecientes al genero vibrio para la profilaxis y terapia de vibrio anguillarum; y composicion antibacteriana que comprende dicha cepas. | |
BR112013024974A2 (pt) | composto, composição farmacêutica, método para o tratamento de infecções virais, e, processo para preparar um composto | |
CL2011002649A1 (es) | Uso de un aerosol que comprende levofloxacina u ofloxacina para preparar un medicamento util para el tratamiento de una infeccion bacteriana pulmonar. | |
EA201500913A1 (ru) | Противомикробные соединения и способы их получения и применения | |
RS53907B1 (en) | USE OF NIFURATEL FOR TREATMENT OF ATOPOBIUM-CAUSED INFECTIONS | |
CL2012003626A1 (es) | Uso de acido cicorico y una bacteria acido lactica para regular la pigmentacion de la piel; metodo de tratamiento estetico; kit para prevenir transtornos de pigmentacion de la piel y/o imperfecciones de la piel. | |
CL2012000694A1 (es) | Composicion farmaceutica que comprende 200-800mg de ceftarolina fosamilo, l-arginina y menos de 2% de un aducto de l-arginina; uso para tratar infecciones de la piel y neumonia bacteriana. | |
PL386175A1 (pl) | Nowe szczepy bakteriofagów do leczenia zakażeń bakteryjnych, zwłaszcza szczepami bakterii lekoopornych rodzaju Enterococcus |